Bayesian Approaches to Randomized Trials
From MaRDI portal
Publication:4785356
DOI10.2307/2983527zbMATH Open1001.62529OpenAlexW1991058132MaRDI QIDQ4785356FDOQ4785356
Authors: David Spiegelhalter, Laurence S. Freedman, Mahesh K. B. Parmar 
Publication date: 1 January 2003
Published in: Journal of the Royal Statistical Society. Series A. Statistics in Society (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2983527
Recommendations
Cited In (63)
- Frequentist operating characteristics of Bayesian optimal designs via simulation
- Decoupling power and type I error rate considerations when incorporating historical control data using a test-then-pool approach
- A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering
- Evaluating futility of a binary clinical endpoint using early read-outs
- The statistical properties of RCTs and a proposal for shrinkage
- A flexible multi-metric Bayesian framework for decision-making in phase II multi-arm multi-stage studies
- Assurance for Sample Size Determination in Reliability Demonstration Testing
- Applying non-parametric robust Bayesian analysis to non-opinionated judicial neutrality
- Optimal healthcare decisions: comparing medical treatments on a cost-effectiveness basis
- Bayesian and likelihood inference for cure rates based on defective inverse Gaussian regression models
- Implementing Bayesian predictive procedures: the \(K\)-prime and \(K\)-square distributions
- Statistical methods in experimentation recommendation models for discovering gene regulation pathways
- Bayesian analysis of multicentre trial outcomes
- Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?
- Bayesian analysis of multicentre trial outcomes
- Bayesian models and methods in public policy and government settings
- Bayesian borrowing for basket trials with longitudinal outcomes
- Bayesian model-averaged meta-analysis in medicine
- Clinician preferences and the estimation of causal treatment differences. (With comments)
- Bayesian index to compare assumed survival functions of two hazards following exponential distributions
- Randomized phase III oncology trials: a survey and empirical Bayes inference
- Two useful distributions for Bayesian predicitve procedures under normal models
- The Performance of Random Coefficient Regression in Accounting for Residual Confounding
- Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
- Bayesian techniques for sample size determination in clinical trials: a short review
- Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II
- Optimal sampling for repeated binary measurements
- Biostatistics in the new millennium: a consulting statistician's perspective
- A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
- Reflections on Fourteen Cryptic Issues Concerning the Nature of Statistical Inference*
- Simulation-based sequential Bayesian design
- Reflections on the concept of optimality of single decision point treatment regimes
- Bayesian statistics and the efficiency and ethics of clinical trials
- Hierarchical Proportional Hazards Regression Models for Highly Stratified Data
- Interim Analysis in Clinical Trials: The Role of the Likelihood Principle
- Approximate Bayesian Evaluation of Multiple Treatment Effects
- Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- Conditional power and friends: the why and how of (un)planned, unblinded sample size recalculations in confirmatory trials
- Bayesian consensus-based sample size criteria for binomial proportions
- Ethical considerations concerning treatment allocation in drug development trials
- Title not available (Why is that?)
- A Bayesian Group Sequential Approach for Multiple Endpoints
- Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
- Prediction markets, Bayesian priors, and clinical trials
- Rejoinder: Approximate models and robust decisions
- Bayesian Evidence Accumulation in Experimental Mathematics: A Case Study of Four Irrational Numbers
- Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
- Bayesian Design and Analysis of Active Control Clinical Trials
- Case-control analysis with partial knowledge of exposure misclassification probabilities
- Determining the Effective Sample Size of a Parametric Prior
- Incorporating external information in analyses of clinical trials with binary outcomes
- Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing
- Why There's No Cause to Randomize
- A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials
- Why should clinicians care about Bayesian methods? (With discussions and response)
- Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests
- Title not available (Why is that?)
- Title not available (Why is that?)
- Incorporating Bayesian ideas into health-care evaluation
- Conservative prior distributions for variance parameters in hierarchical models
- Interpreting \(p\)-values and confidence intervals using well-calibrated null preference priors
- Bayesian approach to determine the number of subsequent users of a new treatment
This page was built for publication: Bayesian Approaches to Randomized Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4785356)
